Experience

DiagnosTear Ltd.

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Chief Technology Officer

  • Oct 2022 - Present

• COO and Acting CEO

  • Sep 2021 - Oct 2022

  Taking responsibility on DiagnosTear success. Leading a large scale clinical study in India consisting of 100 Healthy and 500 Dry Eye patients. Promoting DiagnosTear to its next generation product challenging Red Eye diagnostics.

• Chief Operating Officer

  • Mar 2020 - Aug 2021

  Rejoining DiagnosTear as COO after a recess of 2 years. DiagnoStear has out of the box and promising product for dry eye syndrome. My roll is to bring about the CE approved kit to market.



Rapid BioPass

• Nes Ziona, Israel

• Chief Scientific Officer and co Founder

  • Oct 2020 - Present

  Rapid Bio-Pass is focusing on creating new tools for managing the COVID 19 pandemic. Among others, we develop rapid test identifying healthy individuals that will become asymptomatic in case of infection. Due to the fact that rapid test results are developed as lines, Rapid Bio Pass designed a special barcode that includes test results as part of the code, concealing the actual results from unprofessional eyes. Test results are being sent to the sovereign allowing a better control of the epidemic and breaking the chain of infection. Show less



Rapid BioScience

• Biotechnology Research

• Founder & CEO

  • 2015 - Present

  ► Rapid Bioscience believes in promoting unique ideas in the In Vitro Diagnostic (IVD) arena. ► By granting them with industrial qualities, the biochemical or genetic tools become more attractive to investors. Rapid Bioscience can make it happen within a short period of 3-4 months and with a limited budget. ► Rapid BioScience operates a whet Lab with20 years experienced technician in diagnostic rapid test like ELISA, semi-dry ELISA and lateral flow assays. ► Dr Sommer practices development of lateral flow rapid assays for the past 20 years and accumulated global expertise in this era. As such, Dr Sommer is well experienced with development and production of Point Of Care (POC) tests at doctor's office, emergency room and home testing. ► The company develops assays under Quality Assurance (QA) environment and can provide adequate set of procedures and forms meeting regulations' requirements for medical devices(ISO 9001, ISO 13485 or GMP[ 21CFR820]) Show less



B-Sense

• Consultant

  • Jul 2013 - Mar 2020

  ► Advising companies for IVD technologies. ► Assessing potential of new platforms or concepts. ► Supporting R&D groups - Writing R&D plans, training researchers with designated technologies and assay troubleshooting. ► Implementing quality regulations upon lab work and documentation. ► Among the companies I consult, are: Given Imaging [Covedien], Novamed Ltd and Tatakoto Ltd ► Advising companies for IVD technologies. ► Assessing potential of new platforms or concepts. ► Supporting R&D groups - Writing R&D plans, training researchers with designated technologies and assay troubleshooting. ► Implementing quality regulations upon lab work and documentation. ► Among the companies I consult, are: Given Imaging [Covedien], Novamed Ltd and Tatakoto Ltd



DiagnosTear Ltd.

• Israel
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Vice President of Research and Development

  • Nov 2013 - Apr 2018

  ► Leading an innovative and exiting development of a diagnostic kit (TearX) for the detection of Dry Eye Syndrome. ► Using my 20 years experience and self motivated nature to promote new ideas. ► Searching for new parameters to better characterize this complex syndrome. ► Identification of dry eye sub groups can change pharmaceutical companies' approach for detecting novel remedies. ► Responsible for the entire R&D activity of the start-up company including development plans in accordance to Quality Assurance (QA) regulations, communication with RM and equipment suppliers, importing and assimilating new technologies into the development process. ► I also manage Clinical Studies on different sites. Show less



Alere Inc.

• United States
• Medical Device
• 700 & Above Employee

• Senior Executive at Alere (Orgenics) - Production Scientist

  • Sep 2011 - Jul 2013

  ► Management of Process Development department► Responsible for all scientific aspects and process improvement projects within production► Counseling QA department for production relevant issues

• R&D Senior Researcher & Project Leader

  • Oct 2000 - Sep 2011

  ► Owner of the DoubleCheckGold platform- a known and well appreciated rapid tests for the detection of anti HIV-1 and HIV-2 antibodies in human blood, serum and plasma.► Responsible for transferring ABBOTT technologies to OrgenicsInitiated the upgraded Determine HIV test [ABBOTT Japan) to a highly sensitive test for Ab and Ag detection in human blood.► Led the development of a highly sensitive (0.5ng/ml) HBsAg immunoassay based on the ABBOTT Determine platform.



Novamed

• Israel

• Research and Development Manager

  • Aug 1997 - Sep 2000

  I developed a rapid assy for Rotavirus and a combo test for Rota and Adenovirus. The Rota test replaced the old Latex agglutination test that Macabi labs used, within 3 months. I developed a rapid assy for Rotavirus and a combo test for Rota and Adenovirus. The Rota test replaced the old Latex agglutination test that Macabi labs used, within 3 months.



ZER Hitech

• Jrusalem Israel

• Research and Development Manager

  • Jul 1994 - Mar 1997

  ► Developed a rapid test for pregnancy. ► Started a project of HIV rapid test. ► Managed the regulatory affairs of the company ► Developed a rapid test for pregnancy. ► Started a project of HIV rapid test. ► Managed the regulatory affairs of the company